A Doria

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?
    Alessandro Doria
    Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Semin Nephrol 32:437-44. 2012
  2. ncbi A hierarchical and modular approach to the discovery of robust associations in genome-wide association studies from pooled DNA samples
    Paola Sebastiani
    Department of Biostatistics, Boston University School of Public Health, Boston 02118 MA, USA
    BMC Genet 9:6. 2008
  3. ncbi Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes
    Alessandro Doria
    Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA
    JAMA 300:2389-97. 2008
  4. ncbi Genetics of diabetes complications
    Alessandro Doria
    Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Curr Diab Rep 10:467-75. 2010
  5. ncbi Methods for the study of the genetic determinants of diabetes and its complications
    A Doria
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA, USA
    Przegl Lek 57:7-12. 2000
  6. ncbi A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome
    Claudia Menzaghi
    Research Division, Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes 51:2306-12. 2002
  7. ncbi A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes
    Yuan Yuan Zhang
    Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Obesity (Silver Spring) 14:2119-26. 2006
  8. ncbi Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q
    A Bektas
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Diabetes 48:2246-51. 1999
  9. ncbi Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes
    Teresa Soccio
    Research Division, Joslin Diabetes Center, Boston, MA, USA
    Diabetes 55:2763-70. 2006
  10. ncbi Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
    M T Malecki
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
    Nat Genet 23:323-8. 1999

Research Grants

  1. Variability in Adipokine Genes and Atherosclerosis
    Alessandro Doria; Fiscal Year: 2007
  2. Search for Insulin Resistance Genes in Early Onest T2DM
    Alessandro Doria; Fiscal Year: 2006
  3. SEARCH FOR INSULIN RESISTANCE GENES IN EARLY ONSET NIDDM
    Alessandro Doria; Fiscal Year: 2002
  4. Genetics of Coronary Artery Disease in Type 2 Diabetes
    Alessandro Doria; Fiscal Year: 2010

Detail Information

Publications53

  1. ncbi Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy?
    Alessandro Doria
    Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Semin Nephrol 32:437-44. 2012
    ....
  2. ncbi A hierarchical and modular approach to the discovery of robust associations in genome-wide association studies from pooled DNA samples
    Paola Sebastiani
    Department of Biostatistics, Boston University School of Public Health, Boston 02118 MA, USA
    BMC Genet 9:6. 2008
    ..One of the challenges of the analysis of pooling-based genome wide association studies is to identify authentic associations among potentially thousands of false positive associations...
  3. ncbi Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes
    Alessandro Doria
    Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA 02215, USA
    JAMA 300:2389-97. 2008
    ..However, the magnitude of this effect in the population with diabetes has not been well characterized...
  4. ncbi Genetics of diabetes complications
    Alessandro Doria
    Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Curr Diab Rep 10:467-75. 2010
    ..It is anticipated that the identification of these genes will provide novel insights on the etiology of diabetic complications, with crucial implications for the development of new drugs to prevent the adverse effects of diabetes...
  5. ncbi Methods for the study of the genetic determinants of diabetes and its complications
    A Doria
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, MA, USA
    Przegl Lek 57:7-12. 2000
    ..Several new diabetes loci and genes have already been identified through the strategies outlined above, and many more are expected to be found in the next few years with the completion of the Human Genome Project...
  6. ncbi A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome
    Claudia Menzaghi
    Research Division, Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes 51:2306-12. 2002
    ....
  7. ncbi A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes
    Yuan Yuan Zhang
    Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Obesity (Silver Spring) 14:2119-26. 2006
    ..Our findings suggest that the visfatin/PBEF gene may play a role in determining T2D susceptibility, possibly by modulating chronic, low-grade inflammatory responses...
  8. ncbi Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q
    A Bektas
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Diabetes 48:2246-51. 1999
    ..Rather, they strongly suggest that a previously undetected type 2 diabetes locus exists 50 cM from NIDDM2 on 12q...
  9. ncbi Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes
    Teresa Soccio
    Research Division, Joslin Diabetes Center, Boston, MA, USA
    Diabetes 55:2763-70. 2006
    ..001-0.014). Our findings point to genetic variability at the ADIPOR1 locus as a strong determinant of CAD susceptibility in type 2 diabetes...
  10. ncbi Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
    M T Malecki
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
    Nat Genet 23:323-8. 1999
    ..Our findings suggest that deficient binding of NEUROD1 or binding of a transcriptionally inactive NEUROD1 polypeptide to target promoters in pancreatic islets leads to the development of type 2 diabetes in humans...
  11. ncbi An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene
    M Ristow
    Klinik II und Poliklinik für Innere Medizin, Universitat zu Koln, Cologne, Germany
    Diabetes 47:851-4. 1998
    ..Further studies are needed to elucidate the possible role of frataxin in the pathogenesis of NIDDM...
  12. ncbi The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men
    Lu Qi
    Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA
    Diabetes 54:1607-10. 2005
    ..0019). In conclusion, our study showed significant associations between APM1 G276T and decreased CVD risk and increased plasma adiponectin levels in diabetic men...
  13. ncbi Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes
    Lu Qi
    Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
    Diabetes 55:1512-6. 2006
    ..In conclusion, ADIPOQ promoter polymorphism -11365C-->G was associated with plasma adiponectin levels, whereas polymorphisms -4034A-->C and +276G-->T were associated with CVD risk in diabetic patients...
  14. ncbi Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: a tagging-single nucleotide polymorphism haplotype analysis
    Lu Qi
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Diabetes 56:1586-91. 2007
    ..In conclusion, our data indicate significant associations between ADIPOR1 haplotypes and diabetes risk but do not support a relation between ADIPOR2 variability and the disease...
  15. ncbi Genetic variation at the adiponectin locus and risk of type 2 diabetes in women
    Frank B Hu
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Diabetes 53:209-13. 2004
    ..03-2.08, P = 0.03). These data suggest a potential interaction between the adiponectin genotype and PPAR gamma genotype or obesity, but these analyses should be considered exploratory and require further investigation in larger studies...
  16. ncbi High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up
    Linda H Ficociello
    Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA
    Diabetes Care 33:1337-43. 2010
    ..Here, we prospectively investigated whether baseline uric acid impacts the risk of early progressive renal function loss (early GFR loss) in these patients...
  17. ncbi Genetic markers of increased susceptibility to diabetic nephropathy
    A Doria
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Mass 02215, USA
    Horm Res 50:6-11. 1998
    ..Thus, no genetic marker of increased susceptibility to diabetic nephropathy having clinical utility is currently available. New insights are expected from the systematic scanning of the genome for linkage with diabetic nephropathy...
  18. ncbi Hepatocyte nuclear factor-4gamma: cDNA sequence, gene organization, and mutation screening in early-onset autosomal-dominant type 2 diabetes
    N Plengvidhya
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Diabetes 48:2099-102. 1999
    ..We conclude that genetic variability in the HNF-4gamma gene is unlikely to play a major role in the etiology of early-onset autosomal-dominant type 2 diabetes...
  19. ncbi Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24
    Sung-Hoon Kim
    Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA
    Diabetes 52:2182-6. 2003
    ..Identification of these genes will offer new insights into the pathophysiology of MODY that may, in turn, increase our understanding of the cellular events underlying more common forms of diabetes...
  20. ncbi Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes
    Marcus G Pezzolesi
    Research Division, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Diabetes 58:1403-10. 2009
    ..To search for genes that contribute to diabetic nephropathy, a genome-wide association scan was implemented on the Genetics of Kidneys in Diabetes collection...
  21. ncbi Genetic variability in insulin action inhibitor Ikkbeta (IKBKB) does not play a major role in the development of type 2 diabetes
    Claudia Menzaghi
    Research Division, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA
    J Clin Endocrinol Metab 87:1894-7. 2002
    ..We conclude that sequence differences in the IKBKB gene do not play a major role in either early-onset, autosomal dominant type 2 diabetes, or common forms with a later-onset...
  22. ncbi Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians
    Xiaowei Ma
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    J Clin Endocrinol Metab 87:4407-10. 2002
    ..However, our data suggest a synergistic effect of sequence differences at the resistin locus and obesity on risk of type 2 diabetes. Further studies are needed to confirm this finding in other populations...
  23. ncbi Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes
    A Doria
    Section on Genetics, Joslin Diabetes Center, Boston, MA 02215, USA
    Diabetes Care 22:253-61. 1999
    ..To investigate whether there are forms of early-onset autosomal-dominant type 2 diabetes that are distinct from typical maturity-onset diabetes of the young (MODY) and to characterize their phenotypic characteristics...
  24. ncbi Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes
    Watip Boonyasrisawat
    Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes 56:499-505. 2007
    ..04 and 0.028, respectively). These findings point to variability in the A20/TNFAIP3 gene as a modulator of CAD risk in type 2 diabetes. This effect is mediated by allelic differences in A20 expression...
  25. ncbi A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome
    Lucia Gottardo
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
    Obesity (Silver Spring) 16:205-10. 2008
    ..6, 95% confidence interval 0.4-0.8, P = 0.005). These findings point to IL6ST variants as possible determinants of impaired glucose metabolism and other abnormalities of MS...
  26. ncbi Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect
    Tomasz Klupa
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Diabetes Care 25:2292-301. 2002
    ..To determine the distribution of the age at onset of diabetes (maturity-onset diabetes of the young-3 [MODY3]) and to identify determinants of the onset of diabetes in carriers of HNF-1alpha mutations...
  27. ncbi A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians
    Xiaowei Ma
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
    Hum Mol Genet 13:2197-205. 2004
    ..In conclusion, this comprehensive study of CD36 variability indicates that the common polymorphisms at this locus modulate lipid metabolism and cardiovascular risk in Caucasians...
  28. ncbi Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol
    Latisha Love-Gregory
    Department of Medicine, Center for Human Nutrition, Division of Biostatistics, Washington University School of Medicine, St Louis, MO 63110, USA
    Hum Mol Genet 17:1695-704. 2008
    ..0059). Fifteen additional SNPs associated with HDL-C (P = 0.0028-0.044). We conclude that CD36 variants may impact MetS pathophysiology and HDL metabolism, both predictors of the risk of heart disease and type 2 diabetes...
  29. ncbi The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects
    Jarred B McAteer
    Diabetes Unit Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114, USA
    Diabetes 57:1125-30. 2008
    ..We therefore conducted a new meta-analysis that includes novel unpublished data from the ENPP1 Consortium and recent negative findings from large association studies to address the contribution of K121Q to type 2 diabetes...
  30. ncbi Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study
    Hillary A Keenan
    Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes Care 30:1995-7. 2007
  31. ncbi Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
    Jian Liu
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Nat Med 15:940-5. 2009
    ..Our results showing reduced obesity and diabetes in mice treated with clinically available mast cell-stabilizing agents suggest the potential of developing new therapies for these common human metabolic disorders...
  32. ncbi Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction
    Maciej Borowiec
    Research Division, Department of Medicine, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA
    Proc Natl Acad Sci U S A 106:14460-5. 2009
    ..1. These actions are greatly attenuated by the Ala71Thr mutation. These findings point to BLK as a previously unrecognized modulator of beta-cell function, the deficit of which may lead to the development of diabetes...
  33. ncbi Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study
    Hillary A Keenan
    Research Division, Joslin Diabetes Center, Boston, Massachusetts, USA
    Diabetes 59:2846-53. 2010
    ..To evaluate the extent of pancreatic β-cell function in a large number of insulin-dependent diabetic patients with a disease duration of 50 years or longer (Medalists)...
  34. ncbi Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels
    Yuan Yuan Zhang
    Research Division, Joslin Diabetes Center, Boston, MA 02215, USA
    Atherosclerosis 191:121-7. 2007
    ..To investigate this hypothesis, we examined the effect of genetic variability at the leptin receptor (LEPR) locus on the plasma levels of fibrinogen and CRP--two markers of inflammation and susceptibility to atherosclerosis...
  35. ncbi Mutation screening of the neurogenin-3 gene in autosomal dominant diabetes
    S H Kim
    Section on Genetics and Epidemiology, Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA
    J Clin Endocrinol Metab 86:2320-2. 2001
    ..Rather, they might contribute to common type 2 diabetes, although this finding must be replicated in other populations...
  36. ncbi Trinucleotide repeats at the rad locus. Allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q
    A Doria
    Research Division, Joslin Diabetes Center, Boston, MA 02215
    Diabetes 44:243-7. 1995
    ..84 at recombination fractions of 0.024, 0.001, and 0.03, respectively). The high degree of heterozygosity of these markers will allow large-scale family studies to be performed to test the presence of linkage between rad and NIDDM...
  37. ncbi Examination of PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci on chromosome 8p23
    J S Dunn
    Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, Massachusetts 02215, USA
    Ann Hum Genet 70:587-93. 2006
    ..However, a role cannot be excluded in other populations such as the Japanese, among whom linkage to diabetes is also observed at 8p23 and a non-synonymous mutation has been detected in the PPP1R3B gene...
  38. ncbi Type 2 diabetes locus on 12q15. Further mapping and mutation screening of two candidate genes
    A Bektas
    Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Diabetes 50:204-8. 2001
    ..This locus, however, does not appear to correspond to the PTPRR or CPM, although a contribution of mutations in regulatory regions cannot be excluded at this time...
  39. ncbi The emerging genetic architecture of type 2 diabetes
    Alessandro Doria
    Joslin Diabetes Center, One Joslin Place, Harvard Medical School, Boston, MA 02215, USA
    Cell Metab 8:186-200. 2008
    ....
  40. ncbi Identification and importance of brown adipose tissue in adult humans
    Aaron M Cypess
    Research Division, Joslin Diabetes Center, Boston, MA 02215, USA
    N Engl J Med 360:1509-17. 2009
    ....
  41. ncbi Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23
    Sung-Hoon Kim
    Research Division, Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Diabetes 53:1375-84. 2004
    ..Another novel MODY locus may be present on 2q37. Cloning these new MODY genes may offer insights to disease pathways that are relevant to the cause of common type 2 diabetes...
  42. ncbi Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products
    Nerea Varo
    Donald W Reynolds Cardiovascular Clinical Research Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
    Diab Vasc Dis Res 2:81-7. 2005
    ....
  43. ncbi Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15
    Hillary A Keenan
    Research Division, Joslin Diabetes Center, Section on Genetics and Epidemiology, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA
    Atherosclerosis 196:863-70. 2008
    ..To identify genes involved in this modulation, we performed a 10cM genome screen for linkage with plasma C-reactive protein in 38 extended families including 317 non-diabetic and 177 type 2 diabetic family members (2547 relative pairs)...
  44. ncbi Association of hGrb10 genetic variations with type 2 diabetes in Caucasian subjects
    Rosa Di Paola
    Diabetes Care 29:1181-3. 2006
  45. ncbi Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease
    Claudia Menzaghi
    Research Unit of Diabetology and Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    Diabetes 56:1198-209. 2007
    ....
  46. ncbi The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients
    Simonetta Bacci
    Cardiovascular and Endocrine Department of the Scientific Institute, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    Diabetes Care 27:2015-20. 2004
    ..We investigated whether these genetic markers are determinants of coronary artery disease (CAD) in type 2 diabetic patients...
  47. ncbi PAX4 mutations in Thais with maturity onset diabetes of the young
    Nattachet Plengvidhya
    Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
    J Clin Endocrinol Metab 92:2821-6. 2007
    ..Six maturity onset diabetes of the young (MODY) genes have been discovered to date but account for a small proportion of MODY among Asians, suggesting the existence of other MODY genes in this racial group...
  48. ncbi Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and CKD in whites with type 2 diabetes
    Salvatore De Cosmo
    Am J Kidney Dis 50:688-9. 2007
  49. ncbi Elevated C-reactive protein levels do not correspond to autoimmunity in type 1 diabetes
    Andras Treszl
    Diabetes Care 27:2769-70. 2004
  50. ncbi The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction
    Simonetta Bacci
    Unit of Endocrinology, CSS Scientific Institute, San Giovanni Rotondo, Italy
    Diabetes 54:3021-5. 2005
    ..In conclusion, the ENPP1/PC-1 121Q variant is associated with a progressive deterioration of the IR-atherogenic phenotype; among diabetic individuals, it is also associated with earlier onset of type 2 diabetes and MI...
  51. ncbi Genome-wide associations and metabolic disease: the big revolution
    Alessandro Doria
    Curr Opin Clin Nutr Metab Care 11:363-5. 2008
  52. ncbi Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians
    Claudia Menzaghi
    Research Unit of Diabetology and Endocrinology, Scientific Institute Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo FG Italy
    J Clin Endocrinol Metab 91:2792-5. 2006
    ..Serum levels of resistin are believed to modulate insulin resistance in humans...
  53. ncbi Research profile. Genetics and heart disease.
    Terri Kordella
    Diabetes Forecast 55:71, 73-4,. 2002

Research Grants18

  1. Variability in Adipokine Genes and Atherosclerosis
    Alessandro Doria; Fiscal Year: 2007
    ..abstract_text> ..
  2. Search for Insulin Resistance Genes in Early Onest T2DM
    Alessandro Doria; Fiscal Year: 2006
    ....
  3. SEARCH FOR INSULIN RESISTANCE GENES IN EARLY ONSET NIDDM
    Alessandro Doria; Fiscal Year: 2002
    ....
  4. Genetics of Coronary Artery Disease in Type 2 Diabetes
    Alessandro Doria; Fiscal Year: 2010
    ....